0000899243-22-029203.txt : 20220818 0000899243-22-029203.hdr.sgml : 20220818 20220818184350 ACCESSION NUMBER: 0000899243-22-029203 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220816 FILED AS OF DATE: 20220818 DATE AS OF CHANGE: 20220818 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Robin L CENTRAL INDEX KEY: 0001365035 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38914 FILM NUMBER: 221178484 MAIL ADDRESS: STREET 1: C/O PHASE III MEDICAL, INC. STREET 2: 330 SOUTH SERVICE ROAD, SUITE 120 CITY: MELVILLE STATE: NY ZIP: 11747 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Celularity Inc CENTRAL INDEX KEY: 0001752828 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831702591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 BUSINESS PHONE: (908) 768-2170 MAIL ADDRESS: STREET 1: 170 PARK AVE CITY: FLORHAM PARK STATE: NJ ZIP: 07932 FORMER COMPANY: FORMER CONFORMED NAME: GX Acquisition Corp. DATE OF NAME CHANGE: 20180912 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-08-16 0 0001752828 Celularity Inc CELU 0001365035 Smith Robin L C/O CELULARITY INC. 170 PARK AVENUE FLORHAM PARK NJ 07932 1 0 0 0 Stock Option (Right to Buy) 2.99 2022-08-16 4 A 0 250000 0.00 A 2032-08-16 Class A Common Stock 250000 250000 D Stock Option (Right to Buy) 2.99 2022-08-16 4 A 0 800000 0.00 A 2032-08-16 Class A Common Stock 800000 800000 D This option vested and became exercisable immediately on the grant date. This option is subject to vesting in four equal tranches, based on achievement of certain pre-defined performance targets, and subject to the Reporting Person's continuous service with the Issuer through each such date. /s/ Kyle Fletcher, Attorney-in-Fact 2022-08-18